Dr. Monath is a Partner, Pandemic and Biodefense Fund, Kleiner Perkins
Caufield & Byers. He is also Adjunct Professor, Harvard School of
Public Health. Between 1992 and 2006, Dr Monath was Chief Scientific
Officer and an Executive Director, Acambis (a publicly traded
biopharmaceutical company) where he directed R&D on dengue, West
Nile, Japanese encephalitis, yellow fever, Clostridium difficile,
and smallpox vaccines for defense against b...
more
Dr. Monath is a Partner, Pandemic and Biodefense Fund, Kleiner Perkins
Caufield & Byers. He is also Adjunct Professor, Harvard School of
Public Health. Between 1992 and 2006, Dr Monath was Chief Scientific
Officer and an Executive Director, Acambis (a publicly traded
biopharmaceutical company) where he directed R&D on dengue, West
Nile, Japanese encephalitis, yellow fever,
Clostridium difficile,
and smallpox vaccines for defense against bioterrorism. Monath received
his undergraduate degree from Harvard College and M.D. from Harvard
Medical School and trained in internal medicine at the Peter Bent
Brigham Hospital, Boston. COL Monath retired from the US Army in 1992
after 24 years in the uniformed services. Between 1973-1988, he was
Director, Division of Vector-Borne Viral Diseases, Centers for Disease
Control, Fort Collins CO and from 1989-92 Chief, Virology Division, US
Army Medical Research Institute of Infectious Diseases (USAMRIID). He
is on the editorial board of 5 scientific journals. He received the
Nathanial A. Young Award (1984), the Richard M. Taylor Award (1996),
and the Walter Reed Medal (2002) from the American Society of Tropical
Medicine & Hygiene and was President of that Society (2004-05). He
has served on numerous government and international committees on
infectious diseases, biosecurity, World Health Organization expert
committees and the National Vaccines Advisory Committee (USA). Dr.
Monath has published over 340 papers and edited 6 books on the
epidemiology, immunology and pathogenesis of viruses and on vaccine
development.
less
